MicroRNA-144 Represses Gliomas Progression and Elevates Susceptibility to Temozolomide by Targeting CAV2 and FGF7
Scientific Reports - United Kingdom
doi 10.1038/s41598-020-60218-9
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 5, 2020
Authors
Publisher
Springer Science and Business Media LLC